Short Interest in Kyocera Co. (OTCMKTS:KYOCY) Declines By 75.7%

Kyocera Co. (OTCMKTS:KYOCY) was the target of a significant decline in short interest in February. As of February 28th, there was short interest totalling 10,800 shares, a decline of 75.7% from the February 13th total of 44,400 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of 71,400 shares, the short-interest ratio is currently 0.2 days.

Kyocera Stock Up 3.2 %

Shares of KYOCY opened at $11.76 on Friday. Kyocera has a one year low of $9.21 and a one year high of $14.31. The company has a market cap of $16.57 billion, a P/E ratio of 84.00, a P/E/G ratio of 3.05 and a beta of 0.25. The company has a debt-to-equity ratio of 0.06, a current ratio of 3.20 and a quick ratio of 1.97. The firm has a 50 day simple moving average of $10.96 and a two-hundred day simple moving average of $10.83.

Kyocera (OTCMKTS:KYOCY) last posted its earnings results on Monday, February 3rd. The company reported ($0.08) earnings per share for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.24). Kyocera had a return on equity of 0.82% and a net margin of 1.34%. Research analysts forecast that Kyocera will post 0.32 EPS for the current fiscal year.

Kyocera Company Profile

Kyocera Corporation develops, produces, and distributes products based on fine ceramic technologies in Japan, rest of Asia, Europe, the United States, and internationally. It operates through Core Components Business, Electronic Components Business, and Solutions Business segments. The Core Components Business segment offers components, such as fine ceramic components for semiconductor processing equipment, automotive camera modules, and ceramic packages, as well as organic packages and boards to protect electronic components and ICs to industrial machinery, automotive-related, and the information and communication-related markets; optical components, and jewelry and applied ceramic related products; and medical devices comprising prosthetic joints and dental implants.